TNFSF10 and neoplasm: Interestingly, in contrast to the treatment with lead compounds or vehicle alone, which did not cause tumor shrinkage, the average tumor mass was reduced in the group treated with TRAIL alone (24.8 %), and this reduction was greater in the combination treatment group of TRT-0029 and TRAIL (64.5%) (Figure 6C).